The United States specialty generics market is a dynamic sector characterized by robust growth and significant investment opportunities. As of 2023, this market has achieved a valuation of approximately USD 26.28 billion. With a projected Compound Annual Growth Rate (CAGR) of 9.6%, it is expected to nearly double, reaching an estimated USD 59.97 billion by the end of 2032. This growth...